Demineralized Dentin Matrix

PreclinicalBiologic

CCairo University

Demineralized Dentin Matrix is one of 3 biologic programs targeting Allograft. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

AllograftCompleted

AllograftPreclinical

Completed

Competition

Competitive Landscape

2 competitors in Allograft

#DrugCompanyPhaseTrials

Jardiance

Boehringer Ingelheim

Phase 3

1 2

Amnion Chorion Membrane

MMinia University

Preclinical

1 3

Demineralized Dentin Matrix

CCairo University

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Allograft1 trial

Evaluation of Amnion Chorion Membrane and Demineralized Bone Matrix Putty Allograft in Periodontal Intrabony Defects

Completed·—·N/A·NCT02679209·22 enrolled

Socket Preservation1 trial

Evaluation of Post Extraction Hard Tissue Alteration Following Ridge Preservation in the Esthetic Zone Using Allogeneic Dentin Matrix Versus Demineralized Freeze-Dried Bone Allograft: A Randomized Controlled Clinical Trial

Completed·CCairo University·Preclinical·NCT06318650·22 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Demineralized Dentin Matrix. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Demineralized Dentin Matrix compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Demineralized Dentin Matrix. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Cairo University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Preclinical[1]
Company: CCairo University

Demineralized Dentin Matrix

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Allograft1 trial

Socket Preservation1 trial

References

Drug Info

Quick Facts

Related News